Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The "Immunohematology Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
The global immunohematology market is expected to grow from $2.23 billion in 2022 to $2.34 billion in 2023 at a compound annual growth rate (CAGR) of 4.9%. The Immunohematology market is expected to reach $2.8 billion in 2027 at a CAGR of 5%.
The main products included in the immunohematology analyzers and systems and reagents. Analyzers and systems are automated instruments for blood typing and antibody screening. The technologies used are biochips, erythrocyte-magnetized technology (EMT), gel cards, microplates, polymerase chain reaction (PCR) that are used to treat various diseases such as HIV and hepatitis.
The various applications involved are pretransfusion testing, investigation of immune hemolysis, perinatal testing, blood group phenotyping, leucocyte and platelet serology in end-users such as blood banks, diagnostic and reference laboratories, hospitals and academic and research institutes.
The rising prevalence rate of hematological disorders is expected to propel the growth of the immunohematology market going forward. Hematological disorders are a diverse group of conditions that affect the blood and the components of the blood, such as red blood cells, white blood cells, platelets, and plasma.
Immunohematology is essential for safe and effective blood transfusions, as it helps to prevent transfusion reactions caused by incompatible blood types or the presence of antibodies in the recipient's blood. Immunohematology techniques are also used to diagnose and treat diseases related to the immune system, which may impact the hematological system. Therefore, the rising prevalence rate of hematological disorders is driving the growth of the immunohematology market.
Technological advancements are a popular trend in the immunohematology market. Major companies operating in the immunohematology market are focused on developing innovative technologies to sustain their position in the market. For Instance, in October 2021, Ortho Clinical Diagnostics, a US-based diagnostics company, announced the launch of new capabilities for its Immediate Spin Crossmatch (ISXM) system for ORTHO VISION and ORTHO VISION MAX Analyzers.
The ISXM system is a comprehensive transfusion solution that combines multiple instruments and software applications to streamline and automate immunohematology testing and processing. ISXM is used in blood transfusions to identify ABO blood type incompatibility between recipient serum and plasma and donor red blood cells. Although more laboratories are using electronic crossmatch, many still use full crossmatches (AHG/IAT). An ISXM test must also be finished in addition to a full crossmatch.
In March 2023, Werfen, S.A., a Spain-based diagnostic care company acquired Immucor Inc. for approximately $2 billion. The acquisition aimed to expand Werfen, S.A.'s capabilities in specialized diagnostic testing, particularly for diagnostic solutions. Immucor Inc. is a Spain-based transfusion diagnostics company focused on providing blood tests that are safe, accessible, and affordable.
North America was the largest region in the immunohematology market in 2022. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in immunohematology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the immunohematology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Major players in the immunohematology market are
- Ortho Clinical Diagnostics
- Immunocor Inc.
- Abbott Laboratories
- Siemens Healthineers AG
- Grifols S.A.
- Beckman Coulter Inc.
- Thermo Fisher Scientific Inc.
- Becton, Dickinson and Company
- Merck KGaA
- Bio-Rad Laboratories
- Nihon Kohden Corporation
- Sysmex Corporation
- Danaher Corporation
- Biosystems S.A.
- Roche Holdings AG
- Mindray Medical International Limited
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 275 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value (USD) in 2023 | $2.34 billion |
| Forecasted Market Value (USD) by 2027 | $2.8 billion |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | Global |
Key Topics Covered:
1. Executive Summary
2. Immunohematology Market Characteristics
3. Immunohematology Market Trends And Strategies
4. Immunohematology Market - Macro Economic Scenario
4.1. COVID-19 Impact On Immunohematology Market
4.2. Ukraine-Russia War Impact On Immunohematology Market
4.3. Impact Of High Inflation On Immunohematology Market
5. Immunohematology Market Size And Growth
5.1. Global Immunohematology Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Immunohematology Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Immunohematology Market Segmentation
6.1. Global Immunohematology Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Analyzers And Systems
- Reagents
6.2. Global Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Biochips
- Erythrocyte-Magnetized Technology (Emt)
- Gel Cards
- Microplates
- Polymerase Chain Reaction (PCR)
6.3. Global Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Blood-Related Diseases
- HIV
- Hepatitis
6.4. Global Immunohematology Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Pretransfusion Testing
- Investigation Of Immune Hemolysis
- Perinatal Testing
- Blood Group Phenotyping
- Leucocyte And Platelet Serology
6.5. Global Immunohematology Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Blood Banks
- Diagnostic And Reference Laboratories
- Hospitals
- Academic And Research Institutes
7. Immunohematology Market Regional And Country Analysis
7.1. Global Immunohematology Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Immunohematology Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/dd0e0c
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
